Summary
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for advance research in ConformalFLASH. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.
History
IBA's history began in 1972, when C.E.N. built its first medical proton therapy machine. The company was founded in 1991, when C.E.N. spun-off its medical platform to enable its further commercialisation. IBA then set its sights on capitalising on its particle accelerator technology in a broader range of industries, launching the world's first industrial cyclotron for manufacturing PET trace elements for oncology and cardiac imaging. IBA has since become the market leader amongst its peers and continues to push the boundaries of what’s possible through its imaginative and creative use of particle accelerators.
Mission
We strive to create a better world through our pioneering spirit and the power of accelerator-based technologies, by designing and delivering products, services and solutions that make a difference.
Vision
We believe that, through our expertise and passion, we can capture the power of particle accelerators and use it to transform industries, empower clinicians and drive changes in people’s lives. Our vision is that of a healthier, safer and more prosperous world, enabled by the power of particle accelerators.
Key Team
Ms. Soumya Chandramouli (Chief Financial Officer)
Mr. Frederic Nolf (Chief HR & Sustainability Officer)
Olivier Lechien (Corp. Communication Director)
Mr. Matthias Dierl Ph.D. (Chief Medical Physicist of Radiation Therapy)
Marc Van der Burght (Exec. VP of Proton Therapy Installation)
Recognition and Awards
Ion Beam Applications has won numerous awards and accolades over the years, ranging from the Nobel Prize in Physics to the Technology Pioneer 2020 award from the World Economic Forum. The company was most recently recognised with the 2021 Good Technologies Award for its innovative, visionary and inspiring technological leadership in the application of particle accelerator technology in healthcare.
References
